The global Single-use Bioprocessing market was valued at $6,953.0 million in 2020, and is projected to reach $38,843.8 million by 2030, registering a CAGR of 18.4% from 2021 to 2030.
Single-use bioprocessing technology consists of disposable products that assist in manufacturing biopharmaceutical products. This technology has been rapidly adopted by various biopharmaceutical companies in the recent past. These technologies are applied in monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and other applications. The key factors that drive the market growth include rise in the adoption of single-use technologies, low risk of product cross contamination, cost-effectiveness, and less floor space requirement.
The major factors that propel the growth of the single-use bioprocessing market are growth in demand for biopharmaceuticals, new markets emerging across the world, faster implementation, lower risk of product cross-contamination & lower costs, and lesser environmental impact of single-use bioprocessing technologies. Single-use technology is one of the prominent technologies in the area of manufacturing scale and is widely used in upstream pre-commercial biopharmaceutical manufacturing. The high adoption of these devices is mainly due to their speed and flexibility while maintaining total operating expenditure.
Moreover, high energy efficiency, less space required, low water usage, and less risk of contamination associated with the product are some more factors that propel the revenue growth of the market. Furthermore, automation in the single-use system led to the incorporation of big data-based machine learning, which may help boost product yield and achieve maximum productivity & efficiency in terms of process, and a mainstream approach by many biopharmaceutical manufacturers that fuel the single-use bioprocessing market.
Furthermore, according to the Food and Drug Administration (FDA), 17 biologics were approved in 2018, of which 12 were monoclonal antibodies (mAb), three pegylated enzymes, one protein, and one fusion protein. Therefore, the growth in the number of biological approvals and patent expiry is expected to increase the biopharmaceuticals manufacturing process, ultimately helping to increase the use of single-use bioprocessing over the forecast period. In addition, partnerships between industries and academic institutions have witnessed a significant rise over recent years.
The single-use bioprocessing market in this report is studied on the basis of product, application, method, end user, and region. On the basis of product, the market is divided into bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, mixing systems, tubing assemblies, sampling systems, and others. By application, the market is fragmented into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. By method, the market is classified into filtration, storage, cell culture, mixing, and purification. On the basis of end user, the market is divided into biopharmaceutical manufacturers, life science R&D companies & academic research institutes, and contract research organizations & manufacturers. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Region wise, North America dominated the market in 2020, as there is an on-going trend of introducing novel single-use bioprocessing devices in developed economies such as the U.S. and Canada, and then unveiling it to the rest of the world. North America is known for its healthcare facilities and medical services. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to significant demand for bioprocess equipment including laboratory filtration systems and membrane-based microbial analysis among many others.
The major players operating in the global single-use bioprocessing market are 3M Company, Cesco Bioengineering Co. Ltd., Danaher Corporation, Eppendorf AG., Corning Inc., Getinge Group, Merck KGaA, PBS Biotech, Sartorius Stedim Biotech, and Thermo Fisher Scientific, Inc. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
Key Benefits For Stakeholders
- The report provides in-depth analysis of the global single-use bioprocessing market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global single-use bioprocessing market growth.
Key Market Segments
By Product
- Bioreactors
- Tangential-Flow Filtration Devices
- Depth Filters
- Disposable Filter Cartridges
- Media Bags And Containers
- Mixing Systems
- Tubing Assemblies
- Sampling Systems
- Others
By Application
- Monoclonal Antibody Production
- Vaccine Production
- Plant Cell Cultivation
- Patient Specific Cell Therapies
- Others
By Method
- Filtration
- Storage
- Cell Culture
- Mixing
- Purification
By End User
- Biopharmaceutical Manufacturers
- Life Science RD Companies Academic Research
- Contract Research Organization Manufacturers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Turkey
- South Africa
- Rest of LAMEA
Key Market Players
- 3M Company
- Applikon Biotechnology
- Cesco Bioengineering Co. Ltd.
- Danaher Corporation
- Eppendorf ag
- Merck Millipore
- PBS
- Sartorius Stedim Biotech S.A
- Thermo Fisher Scientific
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT
CHAPTER 5: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION
CHAPTER 6: SINGLE-USE BIOPROCESSING MARKET, BY METHOD
CHAPTER 7: SINGLE-USE BIOPROCESSING MARKET, BY END USER
CHAPTER 8: SINGLE-USE BIOPROCESSING MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
CHAPTER 10: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Single-use Bioprocessing Market,' the single-use bioprocessing market share was valued at $7.0 billion in 2020, and is estimated to reach $38.8 billion by 2030, growing at a CAGR of 18.4% from 2021 to 2030.Rise in the adoption of single-use technologies, lower risk of product cross-contamination, and less floor space requirements drive the single-use bioprocessing market. In addition, single-use bioprocessing technologies are highly efficient and cost-effective, which attract pharmaceutical manufacturers to adopt disposable bioprocessing products, thus propelling the demand for single-use bioprocessing technologies. However, extractability and leachability issues, along with stringent regulations restrain the market growth. Moreover, untapped markets such as China and India offer profitable opportunities to expand this market.
The ingle-use bioprocessing market market growth is expected to witness significant growth during the forecast period due to factors such as advantages offered by Single-Use Technology (SUT), such as significant reduction in capital cost and facility construction time. Along with this, several CMOs and biomanufacturers have shifted their business focus to the production of therapeutics against SARS-CoV-2 infection using disposable technologies. In September 2020, Serum Institute selected ABEC’s Custom Single Run (CSR) technology to accelerate large-scale, single-use manufacturing of nearly 1.0 billion doses of Novavax vaccine, which is designed against COVID-19.
The Single-use bioprocessing market trends in this report is studied on the basis of product, application, method, end user, and region. On the basis of product, the market is divided into bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, mixing systems, tubing assemblies, sampling systems, and others. On the basis of product, the media bags & containers segment currently dominates the global single-use bioprocessing market and is expected to continue this trend during the forecast period owing to single-use bioprocessing media bags & containers used in various bioprocessing processes. In addition, single-use containers are widely used for critical liquid handling applications in the bio manufacturing and biopharmaceutical industries. Moreover, single-use bioprocessing technologies are used in the production of monoclonal antibodies (mAb).
By application, the market is divided into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. On the basis of application, the monoclonal antibody production segment dominated the global single-use bioprocessing market in 2020 and is anticipated to be dominant in the market as monoclonal antibodies are immensely useful to treat various immune disorders and are an integral part of vaccine development.
By method, the market is classified into filtration, storage, cell culture, mixing, and purification. On the basis of method, the filtration segment dominated the global single-use bioprocessing market in 2020 and is anticipated to be dominant in the market as it is a vital method to manufacture biological products such as vaccine, monoclonal antibodies, and others.
On the basis of end user, the market is divided into biopharmaceutical manufacturers, life science R&D companies & academic research institutes, and contract research organizations & manufacturers. On the basis of end user, the biopharmaceutical manufacturers segment dominated the global single-use bioprocessing market in 2020 and is anticipated to be dominant in the market owing to increased adoption of these systems for enhanced production of vaccines, monoclonal antibodies, and personalized medicines.
Region wise, North America dominated the single-use bioprocessing industry in 2020, as there is an on-going trend of introducing novel single-use bioprocessing devices in developed economies such as the U.S. and Canada and then unveiling it to the rest of the world. North America is known for its healthcare facilities and medical services. In addition, rise in the adoption of single-use bioprocessing technologies for various biopharmaceutical applications has propelled the growth of the market. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to significant demand for bioprocess equipment including laboratory filtration systems and membrane-based microbial analysis among many others. In addition, Asia-Pacific witnessed strong growth in both the pharma and laboratory equipment market, which is anticipated to offer lucrative opportunities for single-use bioprocessing products in future.
KEY FINDINGS OF STUDY
- On the basis of product, the media bags & containers segment currently dominates the global single-use bioprocessing market size and is expected to continue this trend during the forecast period owing to single-use bioprocessing media bags & containers are used in various bioprocessing processes.
- On the basis of method, the filtration segment dominated the global single-use bioprocessing industry in 2020 and is anticipated to be dominant in the market as it is a vital method to manufacture biological products such as vaccine, monoclonal antibodies, and others.
- On the basis of application, the monoclonal antibody production segment dominated the global single-use bioprocessing market in 2020 and is projected to be dominant in the market as monoclonal antibodies are immensely useful to treat various immune disorders and are an integral part of vaccine development.
- On the basis of end user, the biopharmaceutical manufacturers segment dominated the global single-use bioprocessing market in 2020 and is expected to be dominant in the market owing to increased adoption of these systems for enhanced production of vaccines, monoclonal antibodies, and personalized medicines.
- Region wise, North America dominated the market in 2020, as there is an on-going trend of introducing novel single-use bioprocessing devices in developed economies
Companies Mentioned
- 3M Company
- Applikon Biotechnology
- Cesco Bioengineering Co. Ltd.
- Danaher Corporation
- Eppendorf ag
- Merck Millipore
- PBS
- Sartorius Stedim Biotech S.A
- Thermo Fisher Scientific
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 6953 million |
| Forecasted Market Value ( USD | $ 38843.8 million |
| Compound Annual Growth Rate | 18.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
